Literature DB >> 14253947

[EFFECT OF ANTIDEPRESSIVES AND GENETIC FACTORS].

J ANGST.   

Abstract

Keywords:  AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; GENETICS; IMIPRAMINE; PSYCHOPHARMACOLOGY

Mesh:

Substances:

Year:  1964        PMID: 14253947

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  11 in total

1.  Differentiation of two genetically specific types of depression by the response to antidepressant drugs.

Authors:  C M Pare; J W Mack
Journal:  J Med Genet       Date:  1971-09       Impact factor: 6.318

2.  Monoamine oxidase and inhibitors.

Authors:  K Goergen
Journal:  Humangenetik       Date:  1970

3.  Differentiation of two genetically specific types of depression by the response to antidepressant drugs.

Authors:  C M Pare
Journal:  Humangenetik       Date:  1970

4.  Antidepressants and tranquillizers: biochemical aspects.

Authors:  M H Bickel
Journal:  Humangenetik       Date:  1970

5.  Clinical significance of plasma imipramine levels.

Authors:  C J Walter
Journal:  Proc R Soc Med       Date:  1971-03

6.  A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.

Authors:  Marcus Ising; Susanne Lucae; Elisabeth B Binder; Thomas Bettecken; Manfred Uhr; Stephan Ripke; Martin A Kohli; Johannes M Hennings; Sonja Horstmann; Stefan Kloiber; Andreas Menke; Brigitta Bondy; Rainer Rupprecht; Katharina Domschke; Bernhard T Baune; Volker Arolt; A John Rush; Florian Holsboer; Bertram Müller-Myhsok
Journal:  Arch Gen Psychiatry       Date:  2009-09

Review 7.  Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.

Authors:  Katarzyna Drozda; Daniel J Müller; Jeffrey R Bishop
Journal:  Pharmacotherapy       Date:  2014-02       Impact factor: 4.705

8.  Brain amine concentrations after monoamine oxidase inhibitor administration.

Authors:  A B Jones; C M Pare; W J Nicholson; K Price; R S Stacey
Journal:  Br Med J       Date:  1972-01-01

Review 9.  Risk-benefit assessment of newer versus older monoamine oxidase (MAO) inhibitors.

Authors:  Y Lecrubier
Journal:  Drug Saf       Date:  1994-04       Impact factor: 5.606

Review 10.  THE PHARMACOTHERAPY OF THE DEPRESSIVE SYNDROME.

Authors:  H E LEHMANN
Journal:  Can Med Assoc J       Date:  1965-04-10       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.